China’s government is slow-rolling approval of its first foreign Covid-19 vaccine out of concern it could undermine confidence in Chinese vaccines
, delivering further evidence of the tenacity of vaccine nationalism in the face ofChinese health authorities worry that public doubts about Chinese vaccines stemming from approval of Germany’s BioNTech SE ’s vaccine could disrupt the country’s plans to use the homegrown shots to reach an ambitious vaccination goal before the end of the year, according to people familiar with the deliberations., which is based on state-of-the-art mRNA technology, by July.
Uncertainty about how much more protection the BioNTech vaccine offers against new variants is also driving the hesitation, the people said. Clinical trials conducted earlier in the pandemic show BioNTech’s vaccine is around 95% effective against symptomatic disease, compared with 51% for Sinovac BioTech Ltd. and 79% for Sinopharm. The Delta variant cuts BioNTech’s efficacy down to 64%, according to data from Israel, while there is
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gov. Abbot Bans Vaccine Mandates — AgainGov. Abbott’s new ban will apply to all Covid-19 vaccines, regardless of FDA approval.
Read more »
WSJ News Exclusive | Biden Administration Plans Covid-19 Vaccine Boosters at Six Months Instead of EightBreaking: The U.S. is likely to approve a Covid-19 booster shot six months after the previous dose rather than eight, a person familiar with the plans said
Read more »
A race against Covid: How Moderna and Pfizer-BioNTech developed vaccines in record timeDeveloping a vaccine in less than a year for a novel pathogen had never been done before Covid-19. This is the behind-the-scenes story of how Moderna and Pfizer-BioNTech did it. Watch “A Race Against Covid” with megtirrell now:
Read more »
Moderna completes submission to FDA for full approval of its Covid-19 vaccineModerna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its Covid-19 vaccine for people age 18 and older.
Read more »
Moderna Requests Full FDA Approval for COVID-19 VaccineModerna has completed its submission to the FDA for full approval of its COVID-19 vaccine for ages 18 and older, the company announced on Wednesday.
Read more »
FDA approval of Pfizer's COVID-19 shot brings temptation to vaccinate kids under 12That’s because once a drug or vaccine has been FDA-approved, doctors have the leeway to prescribe it “off label” — that is, for a use for which it wasn’t specifically approved.
Read more »